(Q34133651)

31 July 2017

1 reference

title

Multiple sclerosis: genomic rewards (English)

1 reference

31 July 2017

0 references

3

Barcellos LF

1 reference

31 July 2017

1

Oksenberg JR

1 reference

31 July 2017

4

Hauser SL

1 reference

31 July 2017

Baranzini SE

2

1 reference

31 July 2017

1 February 2001

1 reference

Journal of Neuroimmunology

31 July 2017

1 reference

31 July 2017

113

1 reference

31 July 2017

171-184

1 reference

31 July 2017

2

1 reference

Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Risk of Multiple Sclerosis Related to Age at Immigration to Israel

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple sclerosis and infectious childhood diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Association mapping of disease loci, by use of a pooled DNA genomic screen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Analysis of a sequenced cDNA library from multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple loci for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Infection and multiple sclerosis: a possible role for superantigens?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

DQB1*0602 confers genetic susceptibility to multiple sclerosis in Afro-Brazilians

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The adhesion molecule and cytokine profile of multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A multilocus genotyping assay for candidate markers of cardiovascular disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Vitamin D3: a transcriptional modulator of the interferon-gamma gene

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Genetic epidemiology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Fracture history and bone loss in patients with MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Viruses and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

On the Risk of Multiple Sclerosis According to Age at Immigration to South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A full genome search in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Association studies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple sclerosis among the United Kingdom-born children of immigrants from the West Indies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Inheritance of susceptibility to experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Pharmacogenomics: translating functional genomics into rational therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Migrant studies in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Late complications of immune deviation therapy in a nonhuman primate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Selected reviews common childhood and adolescent infections and multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Discovery and analysis of inflammatory disease-related genes using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Kinetic PCR Analysis: Real-time Monitoring of DNA Amplification Reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The epidemiology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Decreased IL-3 production by peripheral blood mononuclear cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Perivascular T cells express the pro-inflammatory chemokine RANTES mRNA in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Molecular mechanism of vitamin D receptor action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Shedding of TNF receptors in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Single pass sequencing and physical and genetic mapping of human brain cDNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The use of a genetic map of biallelic markers in linkage studies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Genomewide scan of multiple sclerosis in Finnish multiplex families

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple sclerosis in the faroe islands: I. Clinical and epidemiological features

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Balancing the Th1/Th2 concept in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Diet and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The role of TNFalpha and lymphotoxin in demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Analysis of association at single nucleotide polymorphisms in the APOE region.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The epidemiology of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Circuit simulation of genetic networks.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The British Isles survey of multiple sclerosis in twins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Blood levels of transforming growth factor-beta 1 (TGF-beta1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-beta1b).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Genetics of demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Proteomics to study genes and genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Viking voyages: the origin of multiple sclerosis? An essay in medical history.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Searching for genetic determinants in the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

HLA and prognosis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A population-based study of multiple sclerosis in twins: update.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Quantitative monitoring of gene expression patterns with a complementary DNA microarray

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Parallel human genome analysis: microarray-based expression monitoring of 1000 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Relevance of interleukin 1 receptor antagonist intron 2 polymorphism in Italian MS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Linkage analysis of candidate myelin genes in familial multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Mathematical modeling of gene networks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Genetic analysis of vitamin D related genes in Canadian multiple sclerosis patients. Canadian Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Some misconceptions about understanding autoimmunity through experiments with knockouts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Serial analysis of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Genetic variation in the tumor necrosis factor alpha gene and the outcome of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

How many diseases does it take to map a gene with SNPs?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Meta-analysis of genome searches

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Association and linkage analysis of candidate chromosomal regions in multiple sclerosis: indication of disease genes in 12q23 and 7ptr-15

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

Multiple Sclerosis in Black Children

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900444-6

7 January 2021

10.1016/S0165-5728(00)00444-6

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11164900